Quanterix Collects $15 Million in Series A Venture Round
Luke Timmerman8/25/08
Quanterix, a privately held developer of medical diagnostics technology in Cambridge, MA, has raised $15 million in a Series A financing, according to VentureWire. Arch Venture Partners, Bain Capital, and Flagship Ventures participated in the financing. Tufts University researcher David Walt, a founder of San Diego-based Illumina (NASDAQ: ILMN) is a co-founder of Quanterix. The company’s technology is used to identify single molecules in human blood, which escape detection from standard Elisa diagnostic tests, according to the company’s web site.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
